Major trial tests new pill to protect failing kidneys
NCT ID NCT07419828
Summary
This large, late-stage study is testing whether a new tablet called HRS-1780 can slow the decline of kidney function in adults with chronic kidney disease. Nearly 2,000 participants will take either the new drug or a placebo pill for over two years, in addition to their standard treatments. The main goal is to see if HRS-1780 can better preserve kidney filtering ability compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Clinical Research Center of Kidney Diseases, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
RECRUITINGNanjing, Jiangsu, 210002, China
Contact
Conditions
Explore the condition pages connected to this study.